The CME Group, which dominates roughly 92% of U.S. exchange-traded derivatives, is facing sharp criticism over its recent legal challenge against the Commodity Futures Trading Commission. Jake Chervinsky, head of the Hyperliquid Policy Center, argues that the suit is a blatant effort to stifle competition and protect the exchange’s monopoly. In a social media post, he described the lawsuit as a shocking mistake and an unnecessary aggression that reveals CME as a fearful incumbent rather than a market leader.
According to data from Better Markets cited by the Hyperliquid Policy Center, CME’s overwhelming market share leaves little room for competitors, resulting in higher costs and fewer choices for traders. Chervinsky contends that the lawsuit targets the CFTC’s approval of crypto perpetual futures, which represent the first innovative derivatives product to enter regulated U.S. markets in over a decade. He notes that American traders were previously forced to use offshore platforms for similar products, and now that compliant domestic options exist, CME is trying to close that door.
CME, however, argues that perpetual contracts should be classified as swaps under the Dodd-Frank Act, not futures. The exchange claims the CFTC bypassed proper rulemaking procedures when it approved these products on platforms like Coinbase and Kalshi. Outgoing CME CEO Terrence Duffy stated that the lawsuit is necessary to uphold the law. Meanwhile, the CFTC and SEC have launched a joint public consultation to clarify the definitions of swaps and related derivatives, a move that may address the broader ambiguities highlighted by this dispute.
The Hyperliquid Policy Center emphasizes that this isn’t just about one product—it’s about market access and fairness. Chervinsky warned that CME’s actions could harm innovation and keep U.S. markets less competitive. As the legal battle unfolds, the industry watches closely to see whether regulators will support new entrants or side with the established giant.